{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# AHLT - MIRI\n",
    "# Recognition and classification of drug names"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "import nltk # NLTK Library\n",
    "import xml.etree.ElementTree as ET # ElementTree Library\n",
    "import os\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "from xlm_parsers_functions import *\n",
    "\n",
    "## TODO list\n",
    "# Read and save the data from the xlm files in the appropiate format\n",
    "\n",
    "\n",
    "# Train the first ML model that will identify the drug names from a sentence\n",
    "# Build the necessary data structure that will hold the predictors and the response variable\n",
    "# Train ML models with that data"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Importing the data from the XML files"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sentence_id</th>\n",
       "      <th>sentence_text</th>\n",
       "      <th>entity_id</th>\n",
       "      <th>entity_name</th>\n",
       "      <th>entity_charOffset</th>\n",
       "      <th>entity_type</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>DDI-DrugBank.d481.s0</td>\n",
       "      <td>Milk, milk products, and calcium-rich foods or...</td>\n",
       "      <td>DDI-DrugBank.d481.s0.e0</td>\n",
       "      <td>calcium</td>\n",
       "      <td>25-31</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>DDI-DrugBank.d481.s0</td>\n",
       "      <td>Milk, milk products, and calcium-rich foods or...</td>\n",
       "      <td>DDI-DrugBank.d481.s0.e1</td>\n",
       "      <td>EMCYT</td>\n",
       "      <td>82-86</td>\n",
       "      <td>brand</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>DDI-DrugBank.d419.s0</td>\n",
       "      <td>The concurrent administration of allopurinol a...</td>\n",
       "      <td>DDI-DrugBank.d419.s0.e0</td>\n",
       "      <td>allopurinol</td>\n",
       "      <td>33-43</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>DDI-DrugBank.d419.s0</td>\n",
       "      <td>The concurrent administration of allopurinol a...</td>\n",
       "      <td>DDI-DrugBank.d419.s0.e1</td>\n",
       "      <td>ampicillin</td>\n",
       "      <td>49-58</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>DDI-DrugBank.d419.s0</td>\n",
       "      <td>The concurrent administration of allopurinol a...</td>\n",
       "      <td>DDI-DrugBank.d419.s0.e2</td>\n",
       "      <td>ampicillin</td>\n",
       "      <td>175-184</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>DDI-DrugBank.d419.s1</td>\n",
       "      <td>It is not known whether this potentiation of a...</td>\n",
       "      <td>DDI-DrugBank.d419.s1.e0</td>\n",
       "      <td>ampicillin</td>\n",
       "      <td>45-54</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>DDI-DrugBank.d419.s1</td>\n",
       "      <td>It is not known whether this potentiation of a...</td>\n",
       "      <td>DDI-DrugBank.d419.s1.e1</td>\n",
       "      <td>allopurinol</td>\n",
       "      <td>73-83</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>DDI-DrugBank.d419.s2</td>\n",
       "      <td>In controlled clinical trials of AUGMENTIN XR,...</td>\n",
       "      <td>DDI-DrugBank.d419.s2.e0</td>\n",
       "      <td>AUGMENTIN XR</td>\n",
       "      <td>33-44</td>\n",
       "      <td>brand</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>DDI-DrugBank.d419.s2</td>\n",
       "      <td>In controlled clinical trials of AUGMENTIN XR,...</td>\n",
       "      <td>DDI-DrugBank.d419.s2.e1</td>\n",
       "      <td>allopurinol</td>\n",
       "      <td>80-90</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>DDI-DrugBank.d419.s2</td>\n",
       "      <td>In controlled clinical trials of AUGMENTIN XR,...</td>\n",
       "      <td>DDI-DrugBank.d419.s2.e2</td>\n",
       "      <td>AUGMENTIN XR</td>\n",
       "      <td>96-107</td>\n",
       "      <td>brand</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>DDI-DrugBank.d419.s4</td>\n",
       "      <td>However, this sample size is too small to allo...</td>\n",
       "      <td>DDI-DrugBank.d419.s4.e0</td>\n",
       "      <td>AUGMENTIN XR</td>\n",
       "      <td>126-137</td>\n",
       "      <td>brand</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>DDI-DrugBank.d419.s4</td>\n",
       "      <td>However, this sample size is too small to allo...</td>\n",
       "      <td>DDI-DrugBank.d419.s4.e1</td>\n",
       "      <td>allopurinol</td>\n",
       "      <td>143-153</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>DDI-DrugBank.d419.s5</td>\n",
       "      <td>In common with other broad-spectrum antibiotic...</td>\n",
       "      <td>DDI-DrugBank.d419.s5.e0</td>\n",
       "      <td>broad-spectrum antibiotics</td>\n",
       "      <td>21-46</td>\n",
       "      <td>group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>DDI-DrugBank.d419.s5</td>\n",
       "      <td>In common with other broad-spectrum antibiotic...</td>\n",
       "      <td>DDI-DrugBank.d419.s5.e1</td>\n",
       "      <td>AUGMENTIN XR</td>\n",
       "      <td>49-60</td>\n",
       "      <td>brand</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>DDI-DrugBank.d419.s5</td>\n",
       "      <td>In common with other broad-spectrum antibiotic...</td>\n",
       "      <td>DDI-DrugBank.d419.s5.e2</td>\n",
       "      <td>contraceptives</td>\n",
       "      <td>94-107</td>\n",
       "      <td>group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>DDI-DrugBank.d496.s0</td>\n",
       "      <td>No evidence of interaction of PROCRIT with oth...</td>\n",
       "      <td>DDI-DrugBank.d496.s0.e0</td>\n",
       "      <td>PROCRIT</td>\n",
       "      <td>30-36</td>\n",
       "      <td>brand</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>DDI-DrugBank.d234.s0</td>\n",
       "      <td>Interaction with central nervous system depres...</td>\n",
       "      <td>DDI-DrugBank.d234.s0.e0</td>\n",
       "      <td>central nervous system depressants</td>\n",
       "      <td>17-50</td>\n",
       "      <td>group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>DDI-DrugBank.d234.s0</td>\n",
       "      <td>Interaction with central nervous system depres...</td>\n",
       "      <td>DDI-DrugBank.d234.s0.e1</td>\n",
       "      <td>benzodiazepines</td>\n",
       "      <td>63-77</td>\n",
       "      <td>group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>DDI-DrugBank.d234.s1</td>\n",
       "      <td>however, no deleterious interactions were seen...</td>\n",
       "      <td>DDI-DrugBank.d234.s1.e0</td>\n",
       "      <td>ROMAZICON</td>\n",
       "      <td>52-60</td>\n",
       "      <td>brand</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>DDI-DrugBank.d234.s1</td>\n",
       "      <td>however, no deleterious interactions were seen...</td>\n",
       "      <td>DDI-DrugBank.d234.s1.e1</td>\n",
       "      <td>narcotics</td>\n",
       "      <td>85-93</td>\n",
       "      <td>group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>DDI-DrugBank.d234.s1</td>\n",
       "      <td>however, no deleterious interactions were seen...</td>\n",
       "      <td>DDI-DrugBank.d234.s1.e2</td>\n",
       "      <td>anesthetics</td>\n",
       "      <td>109-119</td>\n",
       "      <td>group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>DDI-DrugBank.d234.s1</td>\n",
       "      <td>however, no deleterious interactions were seen...</td>\n",
       "      <td>DDI-DrugBank.d234.s1.e3</td>\n",
       "      <td>muscle relaxants</td>\n",
       "      <td>122-137</td>\n",
       "      <td>group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>DDI-DrugBank.d234.s2</td>\n",
       "      <td>Particular caution is necessary when using ROM...</td>\n",
       "      <td>DDI-DrugBank.d234.s2.e0</td>\n",
       "      <td>ROMAZICON</td>\n",
       "      <td>43-51</td>\n",
       "      <td>brand</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>DDI-DrugBank.d234.s2</td>\n",
       "      <td>Particular caution is necessary when using ROM...</td>\n",
       "      <td>DDI-DrugBank.d234.s2.e1</td>\n",
       "      <td>cyclic antidepressants</td>\n",
       "      <td>203-224</td>\n",
       "      <td>group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>DDI-DrugBank.d234.s2</td>\n",
       "      <td>Particular caution is necessary when using ROM...</td>\n",
       "      <td>DDI-DrugBank.d234.s2.e2</td>\n",
       "      <td>benzodiazepine</td>\n",
       "      <td>263-276</td>\n",
       "      <td>group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>DDI-DrugBank.d234.s2</td>\n",
       "      <td>Particular caution is necessary when using ROM...</td>\n",
       "      <td>DDI-DrugBank.d234.s2.e3</td>\n",
       "      <td>flumazenil</td>\n",
       "      <td>288-297</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>DDI-DrugBank.d234.s3</td>\n",
       "      <td>The use of ROMAZICON is not recommended in epi...</td>\n",
       "      <td>DDI-DrugBank.d234.s3.e0</td>\n",
       "      <td>ROMAZICON</td>\n",
       "      <td>11-19</td>\n",
       "      <td>brand</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>DDI-DrugBank.d234.s4</td>\n",
       "      <td>Although ROMAZICON exerts a slight intrinsic a...</td>\n",
       "      <td>DDI-DrugBank.d234.s4.e0</td>\n",
       "      <td>ROMAZICON</td>\n",
       "      <td>9-17</td>\n",
       "      <td>brand</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>DDI-DrugBank.d234.s4</td>\n",
       "      <td>Although ROMAZICON exerts a slight intrinsic a...</td>\n",
       "      <td>DDI-DrugBank.d234.s4.e1</td>\n",
       "      <td>benzodiazepine</td>\n",
       "      <td>121-134</td>\n",
       "      <td>group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>DDI-DrugBank.d234.s5</td>\n",
       "      <td>ROMAZICON blocks the central effects of benzod...</td>\n",
       "      <td>DDI-DrugBank.d234.s5.e0</td>\n",
       "      <td>ROMAZICON</td>\n",
       "      <td>0-8</td>\n",
       "      <td>brand</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12899</th>\n",
       "      <td>DDI-DrugBank.d567.s12</td>\n",
       "      <td>Amiodarone or Verapamil: The risk of myopathy/...</td>\n",
       "      <td>DDI-DrugBank.d567.s12.e2</td>\n",
       "      <td>amiodarone</td>\n",
       "      <td>86-95</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12900</th>\n",
       "      <td>DDI-DrugBank.d567.s12</td>\n",
       "      <td>Amiodarone or Verapamil: The risk of myopathy/...</td>\n",
       "      <td>DDI-DrugBank.d567.s12.e3</td>\n",
       "      <td>verapamil</td>\n",
       "      <td>100-108</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12901</th>\n",
       "      <td>DDI-DrugBank.d567.s12</td>\n",
       "      <td>Amiodarone or Verapamil: The risk of myopathy/...</td>\n",
       "      <td>DDI-DrugBank.d567.s12.e4</td>\n",
       "      <td>HMG-CoA reductase inhibitor class</td>\n",
       "      <td>169-201</td>\n",
       "      <td>group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12902</th>\n",
       "      <td>DDI-DrugBank.d567.s13</td>\n",
       "      <td>Coumarin Anticoagulants: In a small clinical t...</td>\n",
       "      <td>DDI-DrugBank.d567.s13.e0</td>\n",
       "      <td>Coumarin Anticoagulant</td>\n",
       "      <td>0-21</td>\n",
       "      <td>group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12903</th>\n",
       "      <td>DDI-DrugBank.d567.s13</td>\n",
       "      <td>Coumarin Anticoagulants: In a small clinical t...</td>\n",
       "      <td>DDI-DrugBank.d567.s13.e1</td>\n",
       "      <td>lovastatin</td>\n",
       "      <td>60-69</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12904</th>\n",
       "      <td>DDI-DrugBank.d567.s13</td>\n",
       "      <td>Coumarin Anticoagulants: In a small clinical t...</td>\n",
       "      <td>DDI-DrugBank.d567.s13.e2</td>\n",
       "      <td>warfarin</td>\n",
       "      <td>91-98</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12905</th>\n",
       "      <td>DDI-DrugBank.d567.s14</td>\n",
       "      <td>However, another HMG-CoA reductase inhibitor h...</td>\n",
       "      <td>DDI-DrugBank.d567.s14.e0</td>\n",
       "      <td>HMG-CoA reductase inhibitor</td>\n",
       "      <td>17-43</td>\n",
       "      <td>group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12906</th>\n",
       "      <td>DDI-DrugBank.d567.s14</td>\n",
       "      <td>However, another HMG-CoA reductase inhibitor h...</td>\n",
       "      <td>DDI-DrugBank.d567.s14.e1</td>\n",
       "      <td>warfarin</td>\n",
       "      <td>168-175</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12907</th>\n",
       "      <td>DDI-DrugBank.d567.s15</td>\n",
       "      <td>Also, bleeding and/or increased prothrombin ti...</td>\n",
       "      <td>DDI-DrugBank.d567.s15.e0</td>\n",
       "      <td>coumarin anticoagulant</td>\n",
       "      <td>93-114</td>\n",
       "      <td>group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12908</th>\n",
       "      <td>DDI-DrugBank.d567.s15</td>\n",
       "      <td>Also, bleeding and/or increased prothrombin ti...</td>\n",
       "      <td>DDI-DrugBank.d567.s15.e1</td>\n",
       "      <td>lovastatin</td>\n",
       "      <td>136-145</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12909</th>\n",
       "      <td>DDI-DrugBank.d567.s16</td>\n",
       "      <td>It is recommended that in patients taking anti...</td>\n",
       "      <td>DDI-DrugBank.d567.s16.e0</td>\n",
       "      <td>anticoagulants</td>\n",
       "      <td>42-55</td>\n",
       "      <td>group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12910</th>\n",
       "      <td>DDI-DrugBank.d567.s16</td>\n",
       "      <td>It is recommended that in patients taking anti...</td>\n",
       "      <td>DDI-DrugBank.d567.s16.e1</td>\n",
       "      <td>lovastatin</td>\n",
       "      <td>105-114</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12911</th>\n",
       "      <td>DDI-DrugBank.d567.s17</td>\n",
       "      <td>Once a stable prothrombin time has been docume...</td>\n",
       "      <td>DDI-DrugBank.d567.s17.e0</td>\n",
       "      <td>coumarin anticoagulants</td>\n",
       "      <td>140-162</td>\n",
       "      <td>group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12912</th>\n",
       "      <td>DDI-DrugBank.d567.s18</td>\n",
       "      <td>If the dose of lovastatin is changed, the same...</td>\n",
       "      <td>DDI-DrugBank.d567.s18.e0</td>\n",
       "      <td>lovastatin</td>\n",
       "      <td>15-24</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12913</th>\n",
       "      <td>DDI-DrugBank.d567.s19</td>\n",
       "      <td>Lovastatin therapy has not been associated wit...</td>\n",
       "      <td>DDI-DrugBank.d567.s19.e0</td>\n",
       "      <td>Lovastatin</td>\n",
       "      <td>0-9</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12914</th>\n",
       "      <td>DDI-DrugBank.d567.s19</td>\n",
       "      <td>Lovastatin therapy has not been associated wit...</td>\n",
       "      <td>DDI-DrugBank.d567.s19.e1</td>\n",
       "      <td>anticoagulants</td>\n",
       "      <td>116-129</td>\n",
       "      <td>group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12915</th>\n",
       "      <td>DDI-DrugBank.d567.s20</td>\n",
       "      <td>Propranolol: In normal volunteers, there was n...</td>\n",
       "      <td>DDI-DrugBank.d567.s20.e0</td>\n",
       "      <td>Propranolol</td>\n",
       "      <td>0-10</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12916</th>\n",
       "      <td>DDI-DrugBank.d567.s20</td>\n",
       "      <td>Propranolol: In normal volunteers, there was n...</td>\n",
       "      <td>DDI-DrugBank.d567.s20.e1</td>\n",
       "      <td>lovastatin</td>\n",
       "      <td>169-178</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12917</th>\n",
       "      <td>DDI-DrugBank.d567.s20</td>\n",
       "      <td>Propranolol: In normal volunteers, there was n...</td>\n",
       "      <td>DDI-DrugBank.d567.s20.e2</td>\n",
       "      <td>propranolol</td>\n",
       "      <td>184-194</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12918</th>\n",
       "      <td>DDI-DrugBank.d567.s21</td>\n",
       "      <td>Digoxin: In patients with hypercholesterolemia...</td>\n",
       "      <td>DDI-DrugBank.d567.s21.e0</td>\n",
       "      <td>Digoxin</td>\n",
       "      <td>0-6</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12919</th>\n",
       "      <td>DDI-DrugBank.d567.s21</td>\n",
       "      <td>Digoxin: In patients with hypercholesterolemia...</td>\n",
       "      <td>DDI-DrugBank.d567.s21.e1</td>\n",
       "      <td>lovastatin</td>\n",
       "      <td>78-87</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12920</th>\n",
       "      <td>DDI-DrugBank.d567.s21</td>\n",
       "      <td>Digoxin: In patients with hypercholesterolemia...</td>\n",
       "      <td>DDI-DrugBank.d567.s21.e2</td>\n",
       "      <td>digoxin</td>\n",
       "      <td>93-99</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12921</th>\n",
       "      <td>DDI-DrugBank.d567.s21</td>\n",
       "      <td>Digoxin: In patients with hypercholesterolemia...</td>\n",
       "      <td>DDI-DrugBank.d567.s21.e3</td>\n",
       "      <td>digoxin</td>\n",
       "      <td>126-132</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12922</th>\n",
       "      <td>DDI-DrugBank.d567.s22</td>\n",
       "      <td>Oral Hypoglycemic Agents: In pharmacokinetic s...</td>\n",
       "      <td>DDI-DrugBank.d567.s22.e0</td>\n",
       "      <td>Hypoglycemic Agents</td>\n",
       "      <td>5-23</td>\n",
       "      <td>group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12923</th>\n",
       "      <td>DDI-DrugBank.d567.s22</td>\n",
       "      <td>Oral Hypoglycemic Agents: In pharmacokinetic s...</td>\n",
       "      <td>DDI-DrugBank.d567.s22.e1</td>\n",
       "      <td>MEVACOR</td>\n",
       "      <td>56-62</td>\n",
       "      <td>brand</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12924</th>\n",
       "      <td>DDI-DrugBank.d567.s22</td>\n",
       "      <td>Oral Hypoglycemic Agents: In pharmacokinetic s...</td>\n",
       "      <td>DDI-DrugBank.d567.s22.e2</td>\n",
       "      <td>glipizide</td>\n",
       "      <td>163-171</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12925</th>\n",
       "      <td>DDI-DrugBank.d567.s22</td>\n",
       "      <td>Oral Hypoglycemic Agents: In pharmacokinetic s...</td>\n",
       "      <td>DDI-DrugBank.d567.s22.e3</td>\n",
       "      <td>chlorpropamide</td>\n",
       "      <td>181-194</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12926</th>\n",
       "      <td>DDI-DrugBank.d376.s0</td>\n",
       "      <td>May interact with addictive medications, espec...</td>\n",
       "      <td>DDI-DrugBank.d376.s0.e0</td>\n",
       "      <td>central nervous system (CNS) depressants</td>\n",
       "      <td>52-91</td>\n",
       "      <td>group</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12927</th>\n",
       "      <td>DDI-DrugBank.d376.s0</td>\n",
       "      <td>May interact with addictive medications, espec...</td>\n",
       "      <td>DDI-DrugBank.d376.s0.e1</td>\n",
       "      <td>alcohol</td>\n",
       "      <td>185-191</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12928</th>\n",
       "      <td>DDI-DrugBank.d376.s0</td>\n",
       "      <td>May interact with addictive medications, espec...</td>\n",
       "      <td>DDI-DrugBank.d376.s0.e2</td>\n",
       "      <td>ethinamate</td>\n",
       "      <td>320-329</td>\n",
       "      <td>drug</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>12929 rows Ã— 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                 sentence_id  \\\n",
       "0       DDI-DrugBank.d481.s0   \n",
       "1       DDI-DrugBank.d481.s0   \n",
       "2       DDI-DrugBank.d419.s0   \n",
       "3       DDI-DrugBank.d419.s0   \n",
       "4       DDI-DrugBank.d419.s0   \n",
       "5       DDI-DrugBank.d419.s1   \n",
       "6       DDI-DrugBank.d419.s1   \n",
       "7       DDI-DrugBank.d419.s2   \n",
       "8       DDI-DrugBank.d419.s2   \n",
       "9       DDI-DrugBank.d419.s2   \n",
       "10      DDI-DrugBank.d419.s4   \n",
       "11      DDI-DrugBank.d419.s4   \n",
       "12      DDI-DrugBank.d419.s5   \n",
       "13      DDI-DrugBank.d419.s5   \n",
       "14      DDI-DrugBank.d419.s5   \n",
       "15      DDI-DrugBank.d496.s0   \n",
       "16      DDI-DrugBank.d234.s0   \n",
       "17      DDI-DrugBank.d234.s0   \n",
       "18      DDI-DrugBank.d234.s1   \n",
       "19      DDI-DrugBank.d234.s1   \n",
       "20      DDI-DrugBank.d234.s1   \n",
       "21      DDI-DrugBank.d234.s1   \n",
       "22      DDI-DrugBank.d234.s2   \n",
       "23      DDI-DrugBank.d234.s2   \n",
       "24      DDI-DrugBank.d234.s2   \n",
       "25      DDI-DrugBank.d234.s2   \n",
       "26      DDI-DrugBank.d234.s3   \n",
       "27      DDI-DrugBank.d234.s4   \n",
       "28      DDI-DrugBank.d234.s4   \n",
       "29      DDI-DrugBank.d234.s5   \n",
       "...                      ...   \n",
       "12899  DDI-DrugBank.d567.s12   \n",
       "12900  DDI-DrugBank.d567.s12   \n",
       "12901  DDI-DrugBank.d567.s12   \n",
       "12902  DDI-DrugBank.d567.s13   \n",
       "12903  DDI-DrugBank.d567.s13   \n",
       "12904  DDI-DrugBank.d567.s13   \n",
       "12905  DDI-DrugBank.d567.s14   \n",
       "12906  DDI-DrugBank.d567.s14   \n",
       "12907  DDI-DrugBank.d567.s15   \n",
       "12908  DDI-DrugBank.d567.s15   \n",
       "12909  DDI-DrugBank.d567.s16   \n",
       "12910  DDI-DrugBank.d567.s16   \n",
       "12911  DDI-DrugBank.d567.s17   \n",
       "12912  DDI-DrugBank.d567.s18   \n",
       "12913  DDI-DrugBank.d567.s19   \n",
       "12914  DDI-DrugBank.d567.s19   \n",
       "12915  DDI-DrugBank.d567.s20   \n",
       "12916  DDI-DrugBank.d567.s20   \n",
       "12917  DDI-DrugBank.d567.s20   \n",
       "12918  DDI-DrugBank.d567.s21   \n",
       "12919  DDI-DrugBank.d567.s21   \n",
       "12920  DDI-DrugBank.d567.s21   \n",
       "12921  DDI-DrugBank.d567.s21   \n",
       "12922  DDI-DrugBank.d567.s22   \n",
       "12923  DDI-DrugBank.d567.s22   \n",
       "12924  DDI-DrugBank.d567.s22   \n",
       "12925  DDI-DrugBank.d567.s22   \n",
       "12926   DDI-DrugBank.d376.s0   \n",
       "12927   DDI-DrugBank.d376.s0   \n",
       "12928   DDI-DrugBank.d376.s0   \n",
       "\n",
       "                                           sentence_text  \\\n",
       "0      Milk, milk products, and calcium-rich foods or...   \n",
       "1      Milk, milk products, and calcium-rich foods or...   \n",
       "2      The concurrent administration of allopurinol a...   \n",
       "3      The concurrent administration of allopurinol a...   \n",
       "4      The concurrent administration of allopurinol a...   \n",
       "5      It is not known whether this potentiation of a...   \n",
       "6      It is not known whether this potentiation of a...   \n",
       "7      In controlled clinical trials of AUGMENTIN XR,...   \n",
       "8      In controlled clinical trials of AUGMENTIN XR,...   \n",
       "9      In controlled clinical trials of AUGMENTIN XR,...   \n",
       "10     However, this sample size is too small to allo...   \n",
       "11     However, this sample size is too small to allo...   \n",
       "12     In common with other broad-spectrum antibiotic...   \n",
       "13     In common with other broad-spectrum antibiotic...   \n",
       "14     In common with other broad-spectrum antibiotic...   \n",
       "15     No evidence of interaction of PROCRIT with oth...   \n",
       "16     Interaction with central nervous system depres...   \n",
       "17     Interaction with central nervous system depres...   \n",
       "18     however, no deleterious interactions were seen...   \n",
       "19     however, no deleterious interactions were seen...   \n",
       "20     however, no deleterious interactions were seen...   \n",
       "21     however, no deleterious interactions were seen...   \n",
       "22     Particular caution is necessary when using ROM...   \n",
       "23     Particular caution is necessary when using ROM...   \n",
       "24     Particular caution is necessary when using ROM...   \n",
       "25     Particular caution is necessary when using ROM...   \n",
       "26     The use of ROMAZICON is not recommended in epi...   \n",
       "27     Although ROMAZICON exerts a slight intrinsic a...   \n",
       "28     Although ROMAZICON exerts a slight intrinsic a...   \n",
       "29     ROMAZICON blocks the central effects of benzod...   \n",
       "...                                                  ...   \n",
       "12899  Amiodarone or Verapamil: The risk of myopathy/...   \n",
       "12900  Amiodarone or Verapamil: The risk of myopathy/...   \n",
       "12901  Amiodarone or Verapamil: The risk of myopathy/...   \n",
       "12902  Coumarin Anticoagulants: In a small clinical t...   \n",
       "12903  Coumarin Anticoagulants: In a small clinical t...   \n",
       "12904  Coumarin Anticoagulants: In a small clinical t...   \n",
       "12905  However, another HMG-CoA reductase inhibitor h...   \n",
       "12906  However, another HMG-CoA reductase inhibitor h...   \n",
       "12907  Also, bleeding and/or increased prothrombin ti...   \n",
       "12908  Also, bleeding and/or increased prothrombin ti...   \n",
       "12909  It is recommended that in patients taking anti...   \n",
       "12910  It is recommended that in patients taking anti...   \n",
       "12911  Once a stable prothrombin time has been docume...   \n",
       "12912  If the dose of lovastatin is changed, the same...   \n",
       "12913  Lovastatin therapy has not been associated wit...   \n",
       "12914  Lovastatin therapy has not been associated wit...   \n",
       "12915  Propranolol: In normal volunteers, there was n...   \n",
       "12916  Propranolol: In normal volunteers, there was n...   \n",
       "12917  Propranolol: In normal volunteers, there was n...   \n",
       "12918  Digoxin: In patients with hypercholesterolemia...   \n",
       "12919  Digoxin: In patients with hypercholesterolemia...   \n",
       "12920  Digoxin: In patients with hypercholesterolemia...   \n",
       "12921  Digoxin: In patients with hypercholesterolemia...   \n",
       "12922  Oral Hypoglycemic Agents: In pharmacokinetic s...   \n",
       "12923  Oral Hypoglycemic Agents: In pharmacokinetic s...   \n",
       "12924  Oral Hypoglycemic Agents: In pharmacokinetic s...   \n",
       "12925  Oral Hypoglycemic Agents: In pharmacokinetic s...   \n",
       "12926  May interact with addictive medications, espec...   \n",
       "12927  May interact with addictive medications, espec...   \n",
       "12928  May interact with addictive medications, espec...   \n",
       "\n",
       "                      entity_id                               entity_name  \\\n",
       "0       DDI-DrugBank.d481.s0.e0                                   calcium   \n",
       "1       DDI-DrugBank.d481.s0.e1                                     EMCYT   \n",
       "2       DDI-DrugBank.d419.s0.e0                               allopurinol   \n",
       "3       DDI-DrugBank.d419.s0.e1                                ampicillin   \n",
       "4       DDI-DrugBank.d419.s0.e2                                ampicillin   \n",
       "5       DDI-DrugBank.d419.s1.e0                                ampicillin   \n",
       "6       DDI-DrugBank.d419.s1.e1                               allopurinol   \n",
       "7       DDI-DrugBank.d419.s2.e0                              AUGMENTIN XR   \n",
       "8       DDI-DrugBank.d419.s2.e1                               allopurinol   \n",
       "9       DDI-DrugBank.d419.s2.e2                              AUGMENTIN XR   \n",
       "10      DDI-DrugBank.d419.s4.e0                              AUGMENTIN XR   \n",
       "11      DDI-DrugBank.d419.s4.e1                               allopurinol   \n",
       "12      DDI-DrugBank.d419.s5.e0                broad-spectrum antibiotics   \n",
       "13      DDI-DrugBank.d419.s5.e1                              AUGMENTIN XR   \n",
       "14      DDI-DrugBank.d419.s5.e2                            contraceptives   \n",
       "15      DDI-DrugBank.d496.s0.e0                                   PROCRIT   \n",
       "16      DDI-DrugBank.d234.s0.e0        central nervous system depressants   \n",
       "17      DDI-DrugBank.d234.s0.e1                           benzodiazepines   \n",
       "18      DDI-DrugBank.d234.s1.e0                                 ROMAZICON   \n",
       "19      DDI-DrugBank.d234.s1.e1                                 narcotics   \n",
       "20      DDI-DrugBank.d234.s1.e2                               anesthetics   \n",
       "21      DDI-DrugBank.d234.s1.e3                          muscle relaxants   \n",
       "22      DDI-DrugBank.d234.s2.e0                                 ROMAZICON   \n",
       "23      DDI-DrugBank.d234.s2.e1                    cyclic antidepressants   \n",
       "24      DDI-DrugBank.d234.s2.e2                            benzodiazepine   \n",
       "25      DDI-DrugBank.d234.s2.e3                                flumazenil   \n",
       "26      DDI-DrugBank.d234.s3.e0                                 ROMAZICON   \n",
       "27      DDI-DrugBank.d234.s4.e0                                 ROMAZICON   \n",
       "28      DDI-DrugBank.d234.s4.e1                            benzodiazepine   \n",
       "29      DDI-DrugBank.d234.s5.e0                                 ROMAZICON   \n",
       "...                         ...                                       ...   \n",
       "12899  DDI-DrugBank.d567.s12.e2                                amiodarone   \n",
       "12900  DDI-DrugBank.d567.s12.e3                                 verapamil   \n",
       "12901  DDI-DrugBank.d567.s12.e4         HMG-CoA reductase inhibitor class   \n",
       "12902  DDI-DrugBank.d567.s13.e0                    Coumarin Anticoagulant   \n",
       "12903  DDI-DrugBank.d567.s13.e1                                lovastatin   \n",
       "12904  DDI-DrugBank.d567.s13.e2                                  warfarin   \n",
       "12905  DDI-DrugBank.d567.s14.e0               HMG-CoA reductase inhibitor   \n",
       "12906  DDI-DrugBank.d567.s14.e1                                  warfarin   \n",
       "12907  DDI-DrugBank.d567.s15.e0                    coumarin anticoagulant   \n",
       "12908  DDI-DrugBank.d567.s15.e1                                lovastatin   \n",
       "12909  DDI-DrugBank.d567.s16.e0                            anticoagulants   \n",
       "12910  DDI-DrugBank.d567.s16.e1                                lovastatin   \n",
       "12911  DDI-DrugBank.d567.s17.e0                   coumarin anticoagulants   \n",
       "12912  DDI-DrugBank.d567.s18.e0                                lovastatin   \n",
       "12913  DDI-DrugBank.d567.s19.e0                                Lovastatin   \n",
       "12914  DDI-DrugBank.d567.s19.e1                            anticoagulants   \n",
       "12915  DDI-DrugBank.d567.s20.e0                               Propranolol   \n",
       "12916  DDI-DrugBank.d567.s20.e1                                lovastatin   \n",
       "12917  DDI-DrugBank.d567.s20.e2                               propranolol   \n",
       "12918  DDI-DrugBank.d567.s21.e0                                   Digoxin   \n",
       "12919  DDI-DrugBank.d567.s21.e1                                lovastatin   \n",
       "12920  DDI-DrugBank.d567.s21.e2                                   digoxin   \n",
       "12921  DDI-DrugBank.d567.s21.e3                                   digoxin   \n",
       "12922  DDI-DrugBank.d567.s22.e0                       Hypoglycemic Agents   \n",
       "12923  DDI-DrugBank.d567.s22.e1                                   MEVACOR   \n",
       "12924  DDI-DrugBank.d567.s22.e2                                 glipizide   \n",
       "12925  DDI-DrugBank.d567.s22.e3                            chlorpropamide   \n",
       "12926   DDI-DrugBank.d376.s0.e0  central nervous system (CNS) depressants   \n",
       "12927   DDI-DrugBank.d376.s0.e1                                   alcohol   \n",
       "12928   DDI-DrugBank.d376.s0.e2                                ethinamate   \n",
       "\n",
       "      entity_charOffset entity_type  \n",
       "0                 25-31        drug  \n",
       "1                 82-86       brand  \n",
       "2                 33-43        drug  \n",
       "3                 49-58        drug  \n",
       "4               175-184        drug  \n",
       "5                 45-54        drug  \n",
       "6                 73-83        drug  \n",
       "7                 33-44       brand  \n",
       "8                 80-90        drug  \n",
       "9                96-107       brand  \n",
       "10              126-137       brand  \n",
       "11              143-153        drug  \n",
       "12                21-46       group  \n",
       "13                49-60       brand  \n",
       "14               94-107       group  \n",
       "15                30-36       brand  \n",
       "16                17-50       group  \n",
       "17                63-77       group  \n",
       "18                52-60       brand  \n",
       "19                85-93       group  \n",
       "20              109-119       group  \n",
       "21              122-137       group  \n",
       "22                43-51       brand  \n",
       "23              203-224       group  \n",
       "24              263-276       group  \n",
       "25              288-297        drug  \n",
       "26                11-19       brand  \n",
       "27                 9-17       brand  \n",
       "28              121-134       group  \n",
       "29                  0-8       brand  \n",
       "...                 ...         ...  \n",
       "12899             86-95        drug  \n",
       "12900           100-108        drug  \n",
       "12901           169-201       group  \n",
       "12902              0-21       group  \n",
       "12903             60-69        drug  \n",
       "12904             91-98        drug  \n",
       "12905             17-43       group  \n",
       "12906           168-175        drug  \n",
       "12907            93-114       group  \n",
       "12908           136-145        drug  \n",
       "12909             42-55       group  \n",
       "12910           105-114        drug  \n",
       "12911           140-162       group  \n",
       "12912             15-24        drug  \n",
       "12913               0-9        drug  \n",
       "12914           116-129       group  \n",
       "12915              0-10        drug  \n",
       "12916           169-178        drug  \n",
       "12917           184-194        drug  \n",
       "12918               0-6        drug  \n",
       "12919             78-87        drug  \n",
       "12920             93-99        drug  \n",
       "12921           126-132        drug  \n",
       "12922              5-23       group  \n",
       "12923             56-62       brand  \n",
       "12924           163-171        drug  \n",
       "12925           181-194        drug  \n",
       "12926             52-91       group  \n",
       "12927           185-191        drug  \n",
       "12928           320-329        drug  \n",
       "\n",
       "[12929 rows x 6 columns]"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Use xlm_element.tag to get the name of the xlm element\n",
    "# Use xlm_element.attrib to get all the attributes of the xlm element as a string\n",
    "\n",
    "# Give the headers name for the final dataset\n",
    "headers = [\n",
    "    'sentence_id', \n",
    "    'sentence_text', \n",
    "    'entity_id', \n",
    "    'entity_name', \n",
    "    'entity_charOffset', \n",
    "    'entity_type'\n",
    "          ]\n",
    "\n",
    "# Parse the DrugBank Files\n",
    "entities_dataset = []\n",
    "parent_directory = '../LaboCase/Train/DrugBank/'\n",
    "for filename in os.listdir(parent_directory):\n",
    "    if filename.endswith(\".xml\"):\n",
    "        # Parse the file\n",
    "        tree = ET.parse(parent_directory + filename)\n",
    "        # Create a list of lists with the interactions of the file\n",
    "        entities_dataset = entities_dataset + listEntitiesFromXML(tree.getroot())\n",
    "\n",
    "# Convert the list into a pd.DataFrame\n",
    "pd.DataFrame(entities_dataset, columns=headers)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[['DDI-DrugBank.d297.s0',\n",
       "  'Formal drug interaction studies have not been conducted with ORENCIA.',\n",
       "  'DDI-DrugBank.d297.s0.e0',\n",
       "  'ORENCIA',\n",
       "  '61-67',\n",
       "  'brand'],\n",
       " ['DDI-DrugBank.d297.s1',\n",
       "  'Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.',\n",
       "  'DDI-DrugBank.d297.s1.e0',\n",
       "  'MTX',\n",
       "  '50-52',\n",
       "  'drug'],\n",
       " ['DDI-DrugBank.d297.s1',\n",
       "  'Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.',\n",
       "  'DDI-DrugBank.d297.s1.e1',\n",
       "  'NSAIDs',\n",
       "  '55-60',\n",
       "  'group'],\n",
       " ['DDI-DrugBank.d297.s1',\n",
       "  'Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.',\n",
       "  'DDI-DrugBank.d297.s1.e2',\n",
       "  'corticosteroids',\n",
       "  '63-77',\n",
       "  'group'],\n",
       " ['DDI-DrugBank.d297.s1',\n",
       "  'Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.',\n",
       "  'DDI-DrugBank.d297.s1.e3',\n",
       "  'TNF blocking agents',\n",
       "  '84-102',\n",
       "  'group'],\n",
       " ['DDI-DrugBank.d297.s1',\n",
       "  'Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.',\n",
       "  'DDI-DrugBank.d297.s1.e4',\n",
       "  'abatacept',\n",
       "  '122-130',\n",
       "  'drug'],\n",
       " ['DDI-DrugBank.d297.s2',\n",
       "  'The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.',\n",
       "  'DDI-DrugBank.d297.s2.e0',\n",
       "  'ORENCIA',\n",
       "  '115-121',\n",
       "  'brand'],\n",
       " ['DDI-DrugBank.d297.s2',\n",
       "  'The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.',\n",
       "  'DDI-DrugBank.d297.s2.e1',\n",
       "  'MTX',\n",
       "  '124-126',\n",
       "  'drug'],\n",
       " ['DDI-DrugBank.d297.s2',\n",
       "  'The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.',\n",
       "  'DDI-DrugBank.d297.s2.e2',\n",
       "  'NSAIDs',\n",
       "  '129-134',\n",
       "  'group'],\n",
       " ['DDI-DrugBank.d297.s2',\n",
       "  'The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.',\n",
       "  'DDI-DrugBank.d297.s2.e3',\n",
       "  'corticosteroids',\n",
       "  '137-151',\n",
       "  'group'],\n",
       " ['DDI-DrugBank.d297.s2',\n",
       "  'The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.',\n",
       "  'DDI-DrugBank.d297.s2.e4',\n",
       "  'TNF blocking agents',\n",
       "  '154-172',\n",
       "  'group'],\n",
       " ['DDI-DrugBank.d297.s2',\n",
       "  'The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.',\n",
       "  'DDI-DrugBank.d297.s2.e5',\n",
       "  'azathioprine',\n",
       "  '175-186',\n",
       "  'drug'],\n",
       " ['DDI-DrugBank.d297.s2',\n",
       "  'The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.',\n",
       "  'DDI-DrugBank.d297.s2.e6',\n",
       "  'chloroquine',\n",
       "  '189-199',\n",
       "  'drug'],\n",
       " ['DDI-DrugBank.d297.s2',\n",
       "  'The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.',\n",
       "  'DDI-DrugBank.d297.s2.e7',\n",
       "  'gold',\n",
       "  '202-205',\n",
       "  'drug'],\n",
       " ['DDI-DrugBank.d297.s2',\n",
       "  'The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.',\n",
       "  'DDI-DrugBank.d297.s2.e8',\n",
       "  'hydroxychloroquine',\n",
       "  '208-225',\n",
       "  'drug'],\n",
       " ['DDI-DrugBank.d297.s2',\n",
       "  'The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.',\n",
       "  'DDI-DrugBank.d297.s2.e9',\n",
       "  'leflunomide',\n",
       "  '228-238',\n",
       "  'drug'],\n",
       " ['DDI-DrugBank.d297.s2',\n",
       "  'The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.',\n",
       "  'DDI-DrugBank.d297.s2.e10',\n",
       "  'sulfasalazine',\n",
       "  '241-253',\n",
       "  'drug'],\n",
       " ['DDI-DrugBank.d297.s2',\n",
       "  'The majority of patients in RA clinical studies received one or more of the following concomitant medications with ORENCIA: MTX, NSAIDs, corticosteroids, TNF blocking agents, azathioprine, chloroquine, gold, hydroxychloroquine, leflunomide, sulfasalazine, and anakinra.',\n",
       "  'DDI-DrugBank.d297.s2.e11',\n",
       "  'anakinra',\n",
       "  '260-267',\n",
       "  'drug'],\n",
       " ['DDI-DrugBank.d297.s3',\n",
       "  'Concurrent administration of a TNF antagonist with ORENCIA has been associated with an increased risk of serious infections and no significant additional efficacy over use of the TNF antagonists alone.',\n",
       "  'DDI-DrugBank.d297.s3.e0',\n",
       "  'TNF antagonist',\n",
       "  '31-44',\n",
       "  'group'],\n",
       " ['DDI-DrugBank.d297.s3',\n",
       "  'Concurrent administration of a TNF antagonist with ORENCIA has been associated with an increased risk of serious infections and no significant additional efficacy over use of the TNF antagonists alone.',\n",
       "  'DDI-DrugBank.d297.s3.e1',\n",
       "  'ORENCIA',\n",
       "  '51-57',\n",
       "  'brand'],\n",
       " ['DDI-DrugBank.d297.s3',\n",
       "  'Concurrent administration of a TNF antagonist with ORENCIA has been associated with an increased risk of serious infections and no significant additional efficacy over use of the TNF antagonists alone.',\n",
       "  'DDI-DrugBank.d297.s3.e2',\n",
       "  'TNF antagonists',\n",
       "  '179-193',\n",
       "  'group'],\n",
       " ['DDI-DrugBank.d297.s4',\n",
       "  'Concurrent therapy with ORENCIA and TNF antagonists is not recommended.',\n",
       "  'DDI-DrugBank.d297.s4.e0',\n",
       "  'ORENCIA',\n",
       "  '24-30',\n",
       "  'brand'],\n",
       " ['DDI-DrugBank.d297.s4',\n",
       "  'Concurrent therapy with ORENCIA and TNF antagonists is not recommended.',\n",
       "  'DDI-DrugBank.d297.s4.e1',\n",
       "  'TNF antagonists',\n",
       "  '36-50',\n",
       "  'group'],\n",
       " ['DDI-DrugBank.d297.s5',\n",
       "  'There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.',\n",
       "  'DDI-DrugBank.d297.s5.e0',\n",
       "  'ORENCIA',\n",
       "  '70-76',\n",
       "  'brand'],\n",
       " ['DDI-DrugBank.d297.s5',\n",
       "  'There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.',\n",
       "  'DDI-DrugBank.d297.s5.e1',\n",
       "  'anakinra',\n",
       "  '109-116',\n",
       "  'drug']]"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "t"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "anaconda-cloud": {},
  "kernelspec": {
   "display_name": "Python [Root]",
   "language": "python",
   "name": "Python [Root]"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.5.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 0
}
